These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33371312)

  • 61. Interaction of platelets and inflammatory endothelium in the development and progression of coronary artery disease.
    Langer HF; Bigalke B; Seizer P; Stellos K; Fateh-Moghadam S; Gawaz M
    Semin Thromb Hemost; 2010 Mar; 36(2):131-8. PubMed ID: 20414827
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intertwining of thrombosis and inflammation in atherosclerosis.
    Croce K; Libby P
    Curr Opin Hematol; 2007 Jan; 14(1):55-61. PubMed ID: 17133101
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.
    Jarre A; Gowert NS; Donner L; Münzer P; Klier M; Borst O; Schaller M; Lang F; Korth C; Elvers M
    Cell Signal; 2014 Sep; 26(9):2040-50. PubMed ID: 24928203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The inflammatory processes in atherogenesis].
    Cichoń N; Lach D; Dziedzic A; Bijak M; Saluk J
    Pol Merkur Lekarski; 2017 Mar; 42(249):125-128. PubMed ID: 28333905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation.
    Cimmino G; Muscoli S; De Rosa S; Cesaro A; Perrone MA; Selvaggio S; Selvaggio G; Aimo A; Pedrinelli R; Mercuro G; Romeo F; Perrone Filardi P; Indolfi C; Coronelli M;
    J Cardiovasc Med (Hagerstown); 2023 May; 24(Suppl 2):e156-e167. PubMed ID: 37186566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelets: key players in vascular inflammation.
    Projahn D; Koenen RR
    J Leukoc Biol; 2012 Dec; 92(6):1167-75. PubMed ID: 22923486
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endothelium-platelet interactions in inflammatory lung disease.
    Tabuchi A; Kuebler WM
    Vascul Pharmacol; 2008; 49(4-6):141-50. PubMed ID: 18625343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
    Suades R; Padró T; Vilahur G; Badimon L
    Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Platelet-derived chemokines in vascular remodeling and atherosclerosis.
    Koenen RR; Weber C
    Semin Thromb Hemost; 2010 Mar; 36(2):163-9. PubMed ID: 20414831
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque.
    Flierl U; Schäfer A
    Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The arterial microenvironment: the where and why of atherosclerosis.
    Yurdagul A; Finney AC; Woolard MD; Orr AW
    Biochem J; 2016 May; 473(10):1281-95. PubMed ID: 27208212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Platelets are a previously unrecognised source of MIF.
    Strüßmann T; Tillmann S; Wirtz T; Bucala R; von Hundelshausen P; Bernhagen J
    Thromb Haemost; 2013 Nov; 110(5):1004-13. PubMed ID: 23846621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelet interactions as therapeutic targets for prevention of atherothrombosis.
    Smid J; Braun-Dullaeus R; Gawaz M; Langer HF
    Future Cardiol; 2009 May; 5(3):285-96. PubMed ID: 19450054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis.
    Ueland T; Otterdal K; Lekva T; Halvorsen B; Gabrielsen A; Sandberg WJ; Paulsson-Berne G; Pedersen TM; Folkersen L; Gullestad L; Oie E; Hansson GK; Aukrust P
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1228-34. PubMed ID: 19498175
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Platelets and chemokines in atherosclerosis: partners in crime.
    Weber C
    Circ Res; 2005 Apr; 96(6):612-6. PubMed ID: 15802619
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Connexins in atherosclerosis.
    Pfenniger A; Chanson M; Kwak BR
    Biochim Biophys Acta; 2013 Jan; 1828(1):157-66. PubMed ID: 22609170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelets in atherosclerosis.
    Lievens D; von Hundelshausen P
    Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Platelets, coagulation, and fibrinolysis in atherosclerosis formation].
    Ishii H; Yoshida M
    Nihon Rinsho; 2011 Jan; 69(1):50-4. PubMed ID: 21226260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of mean platelet volume in predicting thrombotic events.
    Colkesen Y; Muderrisoglu H
    Clin Chem Lab Med; 2012 Apr; 50(4):631-4. PubMed ID: 22112054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.